Teladoc Health (TDOC) Missed Projections Case

S.D. New York

Court

7:24-cv-03849

Case number

02 Nov 2022

Class period Start

20 Feb 2024

Class period End

16 Jul 2024

Lead Plaintiff motion deadline

$TDOC stockholder filed a claim vs. Teladoc Health missing growth estimates for Q4'24 and FY 2024.
On February 21, 2024, announcement of weak 2023 results caused $TDOC to fall 23.6%, losing $822M+ in shareholder value.
Teladoc investors can join this case to be notified about potential recovery.
On February 20, 2024, Teladoc disclosed that 
it failed to reduce marketing spending in 2023, despite previouly announced plans; 
it increased marketing spending on its largest division BetterHelp, with little return for that investment;  
contrary to Company's expectations, BetterHelp’s membership stagnated and then decreased in 2023;
Teladoc’s revenue compared to 2022 and Q4 to Q3 was well below expectations.

On this news, $TDOC fell 23.6%, losing $822M+ in shareholder value.

Considering all the representations, investors have reasons to suspect that  Teladoc Health overstated its 2023 prospects.

One of the investors has already filed a class action against Teladoc in S.D. of New York court for failing to timely disclose the setbacks in its 2023 operations.

Case Status

Lead Plaintiff Submission

Alleged Offence

Misleading Statements,

Failure to Disclose,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

21 February 2024

Filing date

17 May 2024

Lead Plaintiff Deadline

16 July 2024

Teladoc Health (TDOC) Missed Projections Case

Collecting participants…